Sánchez-Torres LJ

Language: Spanish
References: 14
Page: 121-126
PDF size: 380.98 Kb.

ABSTRACT

Introduction: the treatment of some benign bone tumors generates defects whose alternatives for their resolution are varied. Biological reconstructions are the best in many of the cases, and allografts are an easy and safe option, in addition to avoiding the risk of obtaining autografts. We present five cases that can be considered representative of the advantages and versatility of allografts in the treatment of benign bone neoplasms. Material and methods: each case is described by diagnosis, location of the lesion, accompanying circumstances, treatment, complications and evolution to full function and weight bearing. Results: diagnosis were: aneurysmal bone cyst (2), giant cell tumor of bone (1), chondroblastoma (1) and periosteal condroma (1). The treatment were intralesional resections (4), and wide resection (1). No complications occurred. Complete mobility and full load bearing was achieved in all cases. Conclusions: each of the clinical and therapeutic situations must be individualized. The advantages of reconstructions with allografts in the treatment of benign bone tumors outweigh the risks generated by obtaining autografts.

REFERENCES

1. Hakim DN, Pelly T, Kulendran M, Caris JA. Benign tumours of bone: a review. J Bone Oncol. 2015; 4: 37-41.

2. Enneking WF. A system of staging musculoskeletal neoplasms. Clin Orthop Relat Res. 1986; 204: 9-24.

3. Fillingham Y, Jacobs J. Bone grafts and their substitutes. Bone Joint J. 2016; 98-B (1 Suppl A): 6-9.

4. Schmidt AH. Autologous bone graft: is it still the gold standard? Injury. 2021; 52 Suppl 2: S18-S22.

5. Younger EM, Chapman MW. Morbidity at bone graft donor sites. J Orthop Trauma. 1989; 3: 192-195.

6. Gharedaghi M, Peivandi MT, Mazloomi M, Shoorin HR, Hasani M, Seyf P et al. Evaluation of clinical results and complications of structural allograft reconstruction after bone tumor surgery. Arch Bone Jt Surg. 2016; 4 (3): 236-242.

7. Cho Y, Choi Y, Kwon YH, Chung SH, Kim JD. How to overcome complications of allograft transplantation? J Korean Bone Joint Tumor Soc. 2011; 17: 65-72.

8. Heest AV, Swiontkowski M. Bone – graft substitutes. Lancet. 1999; 353 (suppl I): 28-29.

9. Agaram NP, Bredella MA. Aneurysmal bone cyst. In: WHO Classification of tumours editorial board. Soft tissue and bone tumours. Lyon, France: International Agency for Research on Cancer; 2020.

10. Flanagan AM, Larousserie F, O'Donnell PG, Yoshida A. Giant cell tumour of bone. In: WHO classification of tumours editorial board. Soft tissue and bone tumours. Lyon, France: International Agency for Research on Cancer; 2020.

11. Amary F, Bloem JL, Cleven AHG, Konishi E. Chondroblastoma. In: WHO classification of tumours editorial board. Soft tissue and bone tumours. Lyon, France: International Agency for Research on Cancer; 2020.

12. Bridge JA, Cleven AHG, Tirabosco R. Periosteal condroma. In: WHO classification of tumours editorial board. Soft tissue and bone tumours. Lyon, France: International Agency for Research on Cancer; 2020.

13. Roudbari S, Sami SHA, Roudbari M. The clinical results of benign bone tumor treatment with allograft or autograft. Arch Iran Med. 2015; 18 (2): 109-113.

14. Roberts TT, Rosenbaum AJ. Bone grafts, bone substitutes and orthobiologics. The bridge between basic science and clinical advancements in fracture healing. Organogenesis. 2012; 8 (4): 114-124.